Characterization of Breast Lesions with Proton MR Spectroscopy

American Journal of Roentgenology

Volumn 181, Issue 5, 2003, Pages 1273-1274

  Yeh, Eren D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE DERIVATIVE; KI 67 ANTIGEN;

ANGIOGENESIS; BREAST CARCINOMA; BREAST DISEASE; BREAST LESION; CONTRAST ENHANCEMENT; CYSTOSARCOMA PHYLLOIDES; DIAGNOSTIC ACCURACY; GENE OVEREXPRESSION; HUMAN; MITOSIS INDEX; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE NEU; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR VASCULARIZATION;

EID: 0142095203     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.181.5.1811273     Document Type: Note

References (5)

1. Tse GMK, Cheung HS, Pang L-M, et al. Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors. AJR 2003;181: 1267-1272
2. Ore SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001;220:13-30
3. Katz-Brull R, Liven PT, Lenkinski RE. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 2002;94:1197-1203
4. Vartanian RK, Weidner N. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol 1994;144:1188-1194
5. Jagannathan NR, Seenu V, Kumar M. Potential of in vivo proton MR spectroscopy in the assessment of breast lesions without the use of contrast agent. Radiology 2002;223:281-282